10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
10x Genomics (Nasdaq: TXG), a pioneer in single cell and spatial biology, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The company's management team is scheduled to present on Monday, January 13, at 7:30 a.m. Pacific Time.
The presentation will take the format of a fireside chat and will be accessible via live webcast through the 'Investors' section of 10x Genomics' website. For those unable to attend live, the webcast recording will remain available for replay for a minimum of 30 days following the event.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, TXG gained 9.94%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302340408.html
SOURCE 10x Genomics, Inc.